	Screening of nasopharyngeal cancer in high-risk familial cohort: A practical approach using a screening algorithm. Ann Acad Med Singap Wee JJ, Jang IJH, Teo NWY, Loh ICY, Charn TC, Eu DKC, Tsang RKY, Lim MY, Huang LM, Mok PKH, Toh ST, Lim CM. PMID: 38920184 [PubMed - indexed for MEDLINE]
	Quantitative parameter analysis of pretreatment dual-energy computed tomography in nasopharyngeal carcinoma cervical lymph node characteristics and prediction of radiotherapy sensitivity. Radiat Oncol Li Z, Li C, Li L, Yang D, Wang S, Song J, Jiang M, Kang M. PMID: 38918834 [PubMed - indexed for MEDLINE]
	Prognostic significance of platelet‑to‑albumin ratio in patients with nasopharyngeal carcinoma receiving concurrent chemoradiotherapy: a retrospective study of 858 cases. BMC Cancer Hua X, Xu F, Shi W, Long ZQ, Huang X, Duan FF, Wang SF, Zhang C, Wang MD, Ni WQ, Xia W, Chen JY, Gao YS. PMID: 38918690 [PubMed - indexed for MEDLINE]
	Tumor Infiltrating Lymphocytes as an Independent Prognostic Factor in Undifferentiated Nasopharyngeal Carcinoma. Asian Pac J Cancer Prev Febriani V, Indrawati I, Sumpono ASB, Ferronika P, Bawono RG, Dwianingsih EK. PMID: 38918661 [PubMed - indexed for MEDLINE]
	Retrospective study of a novel hematological parameter for predicting the survival of patients with nasopharyngeal carcinoma. PeerJ Tang W, Long G. PMID: 38915379 [PubMed - indexed for MEDLINE]
	Additional PD-1 inhibitor improves complete response to induction chemotherapy in locally advanced nasopharyngeal carcinoma. Front Immunol Yu YF, Lu GZ, Wang RJ, Song YK, Wu SG. PMID: 38911859 [PubMed - indexed for MEDLINE]
	Nab-paclitaxel, cisplatin, and capecitabine versus cisplatin and gemcitabine as first line chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma: randomised phase 3 clinical trial. BMJ Liu GY, Ye YF, Jiang YF, Chen GJ, Xia WX, Huang YS, Gao TS, Liu YM, Hou YT, Li JF, Liu JH, Lu N, Chen CL, Ke LR, Liang H, Bei WX, Li WZ, Dong SH, Liu Q, Xie C, Yao HR, Xiang YQ. PMID: 38897625 [PubMed - indexed for MEDLINE]
	Clinical significance of serum lactate dehydrogenase combined with a multivariate model for predicting the near-term outcome of primary nasopharyngeal carcinoma. Life Sci Liu Y, Pan Z, Wang X, Tian Y, Zhu S, Wang X. PMID: 38897348 [PubMed - indexed for MEDLINE]
	Long-term outcomes after particle radiation therapy in patients with nasopharyngeal adenoid cystic carcinoma. BMC Cancer Hu W, Hu J, Huang Q, Gao J, Zhang H, Kong L. PMID: 38890585 [PubMed - indexed for MEDLINE]
	Penpulimab, an anti-PD-1 antibody, for heavily pretreated metastatic nasopharyngeal carcinoma: a single-arm phase II study. Signal Transduct Target Ther Chen X, Wang W, Zou Q, Zhu X, Lin Q, Jiang Y, Sun Y, Shen L, Wang L, Zou G, Lin X, Lin S, Li M, Wang Y, Xu R, Ao R, Wang R, Lin H, Huang S, Xu T, Li W, Xia M, Xia Y, Wang Z, Li B, Li J, Hu C. PMID: 38890298 [PubMed - indexed for MEDLINE]
	Characterization of unique pattern of immune cell profile in patients with nasopharyngeal carcinoma through flow cytometry and machine learning. J Cell Mol Med Liao LJ, Tsai CC, Li PY, Lee CY, Lin SR, Lai WY, Chen IY, Chang CF, Lee JM, Chiu YL. PMID: 38888489 [PubMed - indexed for MEDLINE]
	The usefulness of narrow-band Imaging (NBI) in nasopharyngeal lesions-Validation of the Ni NBI classification dedicated for vascular pattern in the nasopharynx. PLoS One Klimza H, Ma, Zagaja K, Jackowska J, Banaszewski J, Wierzbicka M. PMID: 38885230 [PubMed - indexed for MEDLINE]
	Strategies to enhance nasopharyngeal carcinoma screening in patients with adult-onset idiopathic inflammatory myopathies. Int J Rheum Dis Tang IYK, Li TWL, Luk LTH, Ho B, Ho R, Lai BTL, Lee PML, So H. PMID: 38873854 [PubMed - indexed for MEDLINE]
	Global, regional and national burdens of Nasopharynx cancer in the adolescents and young adults from 1990 to 2019 and its predictions. BMC Cancer Huang G, Wang Y, Qin B, Zeng J, Tan H, Zhang D, Wang Q. PMID: 38862937 [PubMed - indexed for MEDLINE]
	Locally advanced nasopharyngeal carcinoma in adolescents treated with tomotherapy: Experience at King Faisal Specialist Hospital and Research Centre. Ann Saudi Med Aldakheel A, Aldehaim M, Alwhaid MS, Alhabib R, Anwar MS, Alzayed B, Shehzad K, Ghebeh H, Al-Rajhi N. PMID: 38853474 [PubMed - indexed for MEDLINE]
	New T staging recommendations for recurrent nasopharyngeal carcinoma. J Cancer Res Clin Oncol Zhu M, Li P, Zhang H, Wu L, Min K. PMID: 38850403 [PubMed - indexed for MEDLINE]
	Study on the value of Inhibin B in the diagnosis of nasopharyngeal carcinoma and its correlation with traditional Chinese medicine syndromes: An observational study. Medicine (Baltimore) Ma N, Deng X, Liu Q, Xu F, Guo Q, Yan K, Yang Y, Zou G. PMID: 38847724 [PubMed - indexed for MEDLINE]
	Nasopharyngeal carcinoma with leptomeningeal metastases has been treated with comprehensive treatment for long-term survival: A case report and literature review. Medicine (Baltimore) Yang Y, Jiang J, Liu Y, Feng S, Bu H. PMID: 38847717 [PubMed - indexed for MEDLINE]
	Enhancing efficacy and reducing toxicity: Therapeutic optimization in locoregionally advanced nasopharyngeal carcinoma. Cell Rep Med Jiang W, Lv JW, Tang LL, Sun Y, Chen YP, Ma J. PMID: 38843843 [PubMed - indexed for MEDLINE]
	The Relationship Between the hOGG1 rs1052133 Polymorphism and the Occurrence of Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis. Technol Cancer Res Treat Li G, Yao J, Zhang F, Xu X, Wang S. PMID: 38836311 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 8267

Page 1 of 414



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy